|
Advisory
Committees
Nature and Basis Statements of Conflict(s)
of Interest for Voting Members of FDA Advisory Committee Members
The Agency is revising its procedures
regarding the disclosure of conflicts of interest and waivers for
voting advisory committee members in order to implement the requirements
of section 795 of Pub. L. No. 109-97 (Agriculture, Rural Development,
Food and Drug Administration, and Related Agencies Appropriations
Act, 2006) (Nov. 10, 2005). This information is being provided as
an interim measure to comply with the requirements of this law.
Pharmaceutical Science
Advisory Committee
October 5-6, 2006
Charles Cooney, Ph.D.
• 18 U.S.C. 208 waiver (pdf)
Carol Gloff, Ph.D.
• 18 U.S.C. 208 waiver (pdf)
Melvin Koch, Ph.D.
• 18 U.S.C. 208 waiver (pdf)
Marvin Meyer, Ph.D.
• 18 U.S.C. 208 waiver (pdf)
Kenneth Morris, Ph.D.
• 18 U.S.C. 208 waiver (pdf)
Jurgen Venitz, M.D.
• 18 U.S.C. 208 waiver (pdf)
Page updated:
September 18, 2006
|
|